In the paired cohort, TIM-3 expression in metastatic tumor increased the PA of the whole models of PFS from 71.5 to 74.5% (P < 0.001) and OS from 78.2 to 81% (P = 0.015, Table 5). The gene discussed is HAVCR2; the disease is metastatic neoplasm.